Professional Documents
Culture Documents
Submitted by : Divya
Bsc. Life sciences
Roll no. – 2020/468
Hepatitis B Virus and CRISPR
• Hepatitis B virus (HBV) infection is a major global cause
of liver disease and hepatocellular cancer.
• CRISPR/Cas9 : It has been used to precisely edit HBV genome through double stranded
break (DSB) but that causes chromosomal instability in host cells.
• CRISPR Cytidine base editors (CBE) : Silence genes by generating a premature stop
codon with no off target effect.
(Image taken from: narayanahealth.org )
Steps in CRISPR Cytidine Base Editing
Vector Sequence Direct
Cell culture,
construction analysis of S sequencing for
lentiviral vector
and HBV gene of on-target and
production and
specific sgRNA different HBV off target
transduction.
design. genotypes editing
Detection of
Reverse HBsAg by ELISA
Immuno- Northern Blot
transcription (Enzyme linked
fluorescence Analysis
PCR assay immuno-
sorbent assay.
Experimental Methodology
• A single guide RNA named gRNA_S was designed to edit 30th codon of HBV S gene by selecting
conserved sequence of S gene coding strand.
• LentiAncBE4max-BLAST expression vector was constructed by insertion of AncBE4max
sequence into plasmid LentCas9- BLAST.
• Human embryonic kidney HEK293T and hepatoma PLC/PRF/5 cell lines were used to express
CBE.
• HEK293T cells were plated and transfected with vector, Cas9 and gRNA_S. After 24 hours cell
supernatant was collected, filtered and stored.
• PLC/PRF/5 cells were transduced with lentiviral vector and LV-Cas9. Then these cells were
transduced with sgRNA and harvested.
• 11 possible off target sites in cell lines and sgRNA ->Identified->Amplified-> PCR and Sanger
sequencing.
• For HBsAg detection – RNA was extracted from cells and subjected to : Northern blotting,
ELISA, immunofluorescence and RT-PCR.
RESULTS
1) Design of sgRNA capable of introducing 2) Silencing of HBV S gene by CBE mediated base
premature stop codon in HBV S gene editing (CAG to TAG editing in cells).
3) 71% cells developed a premature stop codon 4) 92% reduction in HBsAg secretion in cells revealed
within S gene. by ELISA.
5) Levels of HBs messenger RNA are significantly 6) Intracellular HBsAg was also reduced by 84%,
decreased, revealed by Northern blot. revealed by immunostaining of HBsAg.
8) PCR and Sequencing confirmed that 95%, 93%, 93%, 9% and 72% S gene sequences of
HBV genotypes B, C, F, and H had binding site of sgRNA.
Discussion
• Loss of HBsAg protein is the only functional cure of HBV infection.
• CRISPR base editors could mediate C to T base substitution in genome by
introducing premature stop codons in HBV S gene.
• This technique has no off target effect hence maintains chromosomal
stability.